Achieve Life Sciences appoints Vaughn Himes, PhD to Board of Directors

ACHIEVE LIFE SCIENCES, INC.

Dr. Himes appointed as director effective March 14, 2022; no committee assignment yet.
Annual cash retainer of $40,000 for Board service.
Initial option grant for 6,600 shares, vesting monthly over 36 months, exercise price at Nasdaq close on grant date.
No arrangements, family relationships, or material interests per Item 404(a) reported.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Vaughn Himes

director

ACHV · ACHIEVE LIFE SCIENCES, INC.

Effective: 2022-03-14
Filed: March 15, 2022, 7:59 PM ET

the Board of Directors (the “ Board ”) of Achieve Life Sciences, Inc. (the “ Company ”) appointed Vaughn Himes, PhD., as a director, effective March 14, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Vaughn Himes was appointed as director at ACHIEVE LIFE SCIENCES, INC..

Action: appointed
Role: director

Exact text from the filing

the Board of Directors (the “ Board ”) of Achieve Life Sciences, Inc. (the “ Company ”) appointed Vaughn Himes, PhD., as a director, effective March 14, 2022.

View on SEC.gov

ACHIEVE LIFE SCIENCES, INC. filing history →

Source: SEC EDGAR

accession 0001564590-22-010148

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.